London university launches app to track coronavirus symptoms
King’s College London is launching a new app that allows users to track coronavirus symptoms, which it hopes will slow the outbreak.
About 5,000 twins and their families from across the UK have been recruited to test the app, which will help researchers identify:
How fast the virus is spreading in different areas
High-risk areas in the country
Which symptoms correspond to the coronavirus
Why some people are more at risk
Why twins? They “enable researchers to separate the effects of genes from environmental factors such as diet, lifestyle, previous illnesses and infections, and the microbes within the gut (microbiome)” the school said in a news release.
The twins will record information about their health on a daily basis, including temperature, tiredness and symptoms such as coughing, breathing problems or headaches. Any participants showing signs of Covid-19 will be sent a home testing kit.
The app will be available to the public without the home testing component, and to health professionals who want to contribute to the research.
German army loses 6 million face masks at Nairobi airport
From CNN’s Stephanie Halasz and Nadine Schmidt in Berlin
The German army has lost six million protective masks at the airport in Nairobi, Kenya, a spokesperson for the German Defense Ministry has told CNN.
The Defense Ministry — tasked by the country’s Health Ministry with sourcing the masks — had ordered the masks from an unnamed commercial company. The German company had confirmed the order, with anticipated receipt by the Health Ministry in Germany, the spokesperson said.
The spokesperson did not know why the masks were lost in Nairobi and did not know where they were originally shipped from. No payment had yet been taken, as it was due on delivery.
Meanwhile, German company Qiagen, which produces diagnostic tests for Covid-19 that it says can give results in just one hour, began shipping tests on Tuesday to the US.
Thierry Bernard, Chief Executive Officer of Qiagen, said: “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States as the first syndromic test not only to detect SARS-CoV-2, but also a range of more than 20 other respiratory targets.
“This is an important step in our commitment to offer a range of solutions to support the public health fight against COVID-19 and dramatically ramp up production. Our teams have responded rapidly to the challenge, implementing 24/7 production of test components, adding staff and investing in expanding production capacity.”
There have been 30,081 cases and 130 deaths recorded in Germany, according to Johns Hopkins University.